[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @bullishbruk Bullish Bullish posts on X about $ibrx, rescue, alc, $capr the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::44545258/interactions)  - X Week XXXXXX -XX% - X Month XXXXXXX +127% - X Months XXXXXXX +1,187% - X Year XXXXXXX +1,850% ### Mentions: XX [#](/creator/twitter::44545258/posts_active)  - X Week XX -XX% - X Month XXX +13% - X Months XXX +428% - X Year XXX +703% ### Followers: XXXXX [#](/creator/twitter::44545258/followers)  - X Week XXXXX +1.40% - X Month XXXXX +7.90% - X Months XXXXX +29% - X Year XXXXX +27% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::44545258/influencer_rank)  ### Social Influence **Social category influence** [finance](/list/finance) XXXXX% [stocks](/list/stocks) XXXX% [currencies](/list/currencies) XXXX% [countries](/list/countries) XXXX% **Social topic influence** [$ibrx](/topic/$ibrx) #2, [rescue](/topic/rescue) 5.41%, [alc](/topic/alc) #68, [$capr](/topic/$capr) #15, [$43m](/topic/$43m) #5, [scott](/topic/scott) 1.35%, [health](/topic/health) 1.35%, [target](/topic/target) 1.35%, [if you](/topic/if-you) 1.35%, [investment](/topic/investment) XXXX% **Top accounts mentioned or mentioned by** [@lorimills4ca42](/creator/undefined) [@drpatsoonshiong](/creator/undefined) [@drmakaryfda](/creator/undefined) [@scottadamssays](/creator/undefined) [@seckennedy](/creator/undefined) [@usfda](/creator/undefined) [@vprasadmdmph](/creator/undefined) [@truedat999](/creator/undefined) [@immunitybio](/creator/undefined) [@realdonaldtrump](/creator/undefined) [@av8rlady](/creator/undefined) [@potus](/creator/undefined) [@maxstradamus21](/creator/undefined) [@carnivoreken](/creator/undefined) [@newsnation](/creator/undefined) [@robertkennedyjr](/creator/undefined) [@chriscuomo](/creator/undefined) [@chaudoan8899](/creator/undefined) [@drpatsoonshiongs](/creator/undefined) [@juliebush](/creator/undefined) **Top assets mentioned** [ImmunityBio, Inc. Common Stock (IBRX)](/topic/$ibrx) [Johnson & Johnson (JNJ)](/topic/johnson-johnson) [Sanofi (SNY)](/topic/sanofi) [Pfizer, Inc. (PFE)](/topic/$pfe) [AstraZeneca PLC (AZN)](/topic/$azn) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Iovance Biotherapeutics, Inc. Common Stock (IOVA)](/topic/$iova) ### Top Social Posts Top posts by engagements in the last XX hours "$IBRX praying for @ScottAdamsSays and wish him a complete recovery wonder of ANKTIVA" [X Link](https://x.com/bullishbruk/status/1997760193300754643) 2025-12-07T20:08Z 2779 followers, 3197 engagements "$IBRX ANKTIVA @US_FDA" [X Link](https://x.com/bullishbruk/status/1997991857708544080) 2025-12-08T11:29Z 2779 followers, 2699 engagements "$IBRX 12/08/25 trading @$2.30 mark this post. Check $CAPR timing investment and $$$$$$ profits for many. Not an investment advice do your DD" [X Link](https://x.com/bullishbruk/status/1998031191979761972) 2025-12-08T14:05Z 2779 followers, XXX engagements "$IBRX IMO X. Anktiva Revenue Exploding Already $43M YTD Q4 run-rate $100M+ 2026 guided $350400M (bladder alone). Street still modeling $200M massive beat coming. X. Papillary Bladder Approval (PDUFA Q1 2026) 90%+ CR durability in CIS data instant label expansion another $300500M peak sales add-on. X. QUILT-88 Pancreatic Survival Update (ASCO/GI 2026) Current mOS 10+ mo (3L+) vs historical X mo full data drop likely shows 1214 mo HR XXX. First-ever survival win in pancreatic orphan + fast-track upside. X. ResQ201A NSCLC Phase X Topline (mid-2026) Anktiva + pembro vs pembro in 1L lymphopenic" [X Link](https://x.com/bullishbruk/status/1998034398252327360) 2025-12-08T14:18Z 2779 followers, 1603 engagements "@ImmunityBio Lung Cancer Plans: Early 2025: Announced intent to file BLA for 2nd/3rd-line NSCLC (post-checkpoint failure) based on QUILT-3.055 Phase X (mOS 14-18 months vs. chemos 7-10). Reality: No filing yet. Shifted to new Phase X (ResQ201A with BeiGenes tislelizumab) for confirmationstill enrolling. They didnt renege; Phase X wasnt registrational enough for FDA. Clinical proof: QUILT-3.055 (NSCLC post-CPI): XX% maintained ALC 1000/L; correlated with mOS benefit. Pancreatic (QUILT-88): Lymphopenia reversal prolonged OS in 3rd-6th line. NMIBC (QUILT-3.032): XX% CR rate DOR XX months" [X Link](https://x.com/bullishbruk/status/1987380679470891079) 2025-11-09T04:44Z 2780 followers, XXX engagements "$IBRX @POTUS #ABOLISHTHEFDA A mother watches her 12-year-old waste away from glioblastoma while the FDA sits on paperwork. A father begs on his knees for Anktivathe drug already FDA-approved for bladder cancer already reversing lymphopenia and buying precious months in trialsyet the same agency says wait. Wait while the tumor grows. Wait while the child dies. This isnt caution. This is cruelty dressed up as regulation. Cancer doesnt file forms in triplicate. It kills. Every delayed approval every denied compassionate use every not enough data is another coffin. We are DONE watching our loved" [X Link](https://x.com/bullishbruk/status/1993322293460689038) 2025-11-25T14:14Z 2780 followers, 2976 engagements "I understand that and share counts means nothing. $IBRX .98B Pharma companies with shares outstanding (Nov 2025) Pfizer (PFE) XXXX billion shares Novo Nordisk (NVO) XXXX billion shares AstraZeneca (AZN) XXXX billion shares Merck (MRK) XXXX billion shares Sanofi (SNY) XXXX billion shares Johnson & Johnson (JNJ) XXXX billion shares Bristol-Myers Squibb (BMY) XXXX billion shares GlaxoSmithKline (GSK) XXXX billion shares Novartis (NVS) XXXX billion shares AbbVie (ABBV) XXXX billion shares Chugai Pharmaceutical XXXX billion shares Gilead Sciences (GILD) XXXX billion shares" [X Link](https://x.com/bullishbruk/status/1994515310045774276) 2025-11-28T21:14Z 2779 followers, XXX engagements "$IBRX There is a Strong Support for Dr. Patrick Soon-Shiongs FDA Meeting on Anktiva Dr. Patrick Soon-Shiong meting with the FDA today (Dec X 2025) to secure broader access to Anktiva for BCG-unresponsive papillary-only bladder cancer patients the group currently facing radical cystectomy (bladder removal) as their only remaining option. The evidence is now peer-reviewed and published in the Journal of Urology (Nov 2025 PMID 40956664): 36-month bladder preservation rate: XX% Disease-free survival: XX% Progression-free survival: XX% Only X% Grade X side effects zero Grade XX Median time to" [X Link](https://x.com/bullishbruk/status/1996257639114932369) 2025-12-03T16:38Z 2779 followers, 8358 engagements "$IBRX ANKTIVA should be fast-tracked for two life-changing approvals and then yes move toward the boldest access possible: X. Papillary BCG-unresponsive NMIBC The 36-month data is published and undeniable: XX% bladder preservation XX% progression-free near-perfect safety. Thousands face cystectomy right now. Approve the label expansion immediately. X. Lymphopenia (low ALC) the silent killer hiding in plain sight on every CBC Low lymphocytes independently predict death across cancer chemo sepsis infection radiation and aging. Anktiva is the first and only therapy proven to reverse it by" [X Link](https://x.com/bullishbruk/status/1996597557338816749) 2025-12-04T15:08Z 2779 followers, 4663 engagements "$IBRX: Oh look Andrew Caravello DCVaxdefender and the $NWBO clown Bag holders parade are back at it bravely declaring ANKTIVA is overhyped with no real-world impact and wont change outcomes. 😂 How adorable. Must be tough watching a real FDA-approved drug while clutching their 20-year-old PowerPoint slides. Reality check boys: XX% CR DoR stretching past XX months XX% of papillary patients still have their bladders Actual approval actual patients actual results Meanwhile DCVax-L is still doing the any day now dance outside the US. Keep coping kingsyour tears fuel the $IBRX rocket. 🚀🤡" [X Link](https://x.com/bullishbruk/status/1996813132195414264) 2025-12-05T05:25Z 2780 followers, 3718 engagements "$IBRX with the new FDA policy updates cutting red tape IMO IF and when @ImmunityBio all ongoing trials get approved. huge potential and life changing opportunity ANKTIVA Peak U.S. Market Opportunities NMIBC (CIS + Papillary): $1.5B$2B Pancreatic (lymphopenia reversal): $1.2B$1.8B NSCLC (lymphopenia + checkpoint rescue): $2.5B$3.5B All Solid Tumors lymphopenia BioShield: $5B$7B Recurrent GBM: $2B$3B Long COVID immune restoration: $20B$100B (global XXX yr) Broad checkpoint combo upside: $20B$30B additive. We are looking at $60B-$130B+ market potential GLTL not an investment advice please do" [X Link](https://x.com/bullishbruk/status/1996989437742399676) 2025-12-05T17:05Z 2781 followers, 1385 engagements "$IBRX BioShield for Lymphopenia my Bull Case w/ Projections FDA aggressively fast-tracking ANKTIVA as the first lymphocyte rescue agent (Neupogen for T/NK cells). Pure supportive-care label zero threat to chemo radiation or $MRKs Keytruda empire. Financial Projections (Analyst Consensus Dec 2025): 2025 Revenue: $100120M (up XXX% YoY on ANKTIVA bladder sales; YTD $43M thru Q2 +246% units) 2026 Revenue: $200500M base (lymphopenia launch Q1Q2 adds $150300M; peak potential $510B/yr in U.S. alone per market models capturing 5070% of metastatic patients) EPS: -$0.53 (2025) -$0.10 (2026);" [X Link](https://x.com/bullishbruk/status/1997527398301024397) 2025-12-07T04:43Z 2779 followers, 5135 engagements "$IBRX ANKTIVA" [X Link](https://x.com/bullishbruk/status/1997643172034261312) 2025-12-07T12:23Z 2779 followers, 1342 engagements "$IBRX ANKTIVA to the rescue" [X Link](https://x.com/bullishbruk/status/1997665956831650210) 2025-12-07T13:54Z 2780 followers, XXX engagements "$IBRX Adam I know you are poking but @DrPatSoonShiong will never give you a time of the day. You know people can listen to what @ScottAdamsSays exact words and he never said ANKTIVA (Bioshield) not helping. You getting soft brother come on credibility is everything. STAT losing membership What is wrong brother Hope all is well" [X Link](https://x.com/bullishbruk/status/1997817060374491599) 2025-12-07T23:54Z 2779 followers, 1617 engagements "$IBRX @DrPatSoonShiong on the world stage representing LA and USA proud of him ANKTIVA" [X Link](https://x.com/bullishbruk/status/1997822895280812403) 2025-12-08T00:17Z 2779 followers, 1933 engagements "$IBRX ANKTIVA TO THE RESCUE@ScottAdamsSays" [X Link](https://x.com/bullishbruk/status/1997997156360179896) 2025-12-08T11:50Z 2778 followers, XXX engagements "$IBRX ANKTIVA to the rescue @ScottAdamsSays" [X Link](https://x.com/bullishbruk/status/1997997290619867339) 2025-12-08T11:50Z 2778 followers, XXX engagements "$IBRX an alarming situation" [X Link](https://x.com/bullishbruk/status/1998026126728605892) 2025-12-08T13:45Z 2780 followers, 1694 engagements "$IBRX ANKTIVA to the recuse" [X Link](https://x.com/bullishbruk/status/1998025128224170111) 2025-12-08T13:41Z 2779 followers, 1123 engagements "Open Letter to President Trump Mr. President You said God spared you for a reason. This is the reason. Right now ANKTIVA is quietly curing people doctors had already sentenced to death: XX% complete remission in the worst bladder cancer (most still cancer-free XX years later Stage-4 pancreatic patients alive XXX years after metastasis Kids with no options breathing again because their NK cells woke up and slaughtered the tumors One thousand Americans have already been saved. Ten thousand more are begging for access tonight. Theyre tagging you on X crying in waiting rooms holding up signs that" [X Link](https://x.com/bullishbruk/status/1994408866772029599) 2025-11-28T14:11Z 2779 followers, 47.3K engagements "Here are my top SC biotech stocks $CADL $IBRX $IOVA these three among others may be a life changing opportunity $CAPR that was huge bank Not a financial advice please do your own DD" [X Link](https://x.com/bullishbruk/status/1998036021179720090) 2025-12-08T14:24Z 2779 followers, 1206 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@bullishbruk Bullish
Bullish posts on X about $ibrx, rescue, alc, $capr the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXXX -XX%
- X Month XXXXXXX +127%
- X Months XXXXXXX +1,187%
- X Year XXXXXXX +1,850%
Mentions: XX #
- X Week XX -XX%
- X Month XXX +13%
- X Months XXX +428%
- X Year XXX +703%
Followers: XXXXX #
- X Week XXXXX +1.40%
- X Month XXXXX +7.90%
- X Months XXXXX +29%
- X Year XXXXX +27%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence finance XXXXX% stocks XXXX% currencies XXXX% countries XXXX%
Social topic influence $ibrx #2, rescue 5.41%, alc #68, $capr #15, $43m #5, scott 1.35%, health 1.35%, target 1.35%, if you 1.35%, investment XXXX%
Top accounts mentioned or mentioned by @lorimills4ca42 @drpatsoonshiong @drmakaryfda @scottadamssays @seckennedy @usfda @vprasadmdmph @truedat999 @immunitybio @realdonaldtrump @av8rlady @potus @maxstradamus21 @carnivoreken @newsnation @robertkennedyjr @chriscuomo @chaudoan8899 @drpatsoonshiongs @juliebush
Top assets mentioned ImmunityBio, Inc. Common Stock (IBRX) Johnson & Johnson (JNJ) Sanofi (SNY) Pfizer, Inc. (PFE) AstraZeneca PLC (AZN) Merck & Co., Inc. (MRK) Iovance Biotherapeutics, Inc. Common Stock (IOVA)
Top Social Posts
Top posts by engagements in the last XX hours
"$IBRX praying for @ScottAdamsSays and wish him a complete recovery wonder of ANKTIVA"
X Link 2025-12-07T20:08Z 2779 followers, 3197 engagements
"$IBRX ANKTIVA @US_FDA"
X Link 2025-12-08T11:29Z 2779 followers, 2699 engagements
"$IBRX 12/08/25 trading @$2.30 mark this post. Check $CAPR timing investment and $$$$$$ profits for many. Not an investment advice do your DD"
X Link 2025-12-08T14:05Z 2779 followers, XXX engagements
"$IBRX IMO X. Anktiva Revenue Exploding Already $43M YTD Q4 run-rate $100M+ 2026 guided $350400M (bladder alone). Street still modeling $200M massive beat coming. X. Papillary Bladder Approval (PDUFA Q1 2026) 90%+ CR durability in CIS data instant label expansion another $300500M peak sales add-on. X. QUILT-88 Pancreatic Survival Update (ASCO/GI 2026) Current mOS 10+ mo (3L+) vs historical X mo full data drop likely shows 1214 mo HR XXX. First-ever survival win in pancreatic orphan + fast-track upside. X. ResQ201A NSCLC Phase X Topline (mid-2026) Anktiva + pembro vs pembro in 1L lymphopenic"
X Link 2025-12-08T14:18Z 2779 followers, 1603 engagements
"@ImmunityBio Lung Cancer Plans: Early 2025: Announced intent to file BLA for 2nd/3rd-line NSCLC (post-checkpoint failure) based on QUILT-3.055 Phase X (mOS 14-18 months vs. chemos 7-10). Reality: No filing yet. Shifted to new Phase X (ResQ201A with BeiGenes tislelizumab) for confirmationstill enrolling. They didnt renege; Phase X wasnt registrational enough for FDA. Clinical proof: QUILT-3.055 (NSCLC post-CPI): XX% maintained ALC 1000/L; correlated with mOS benefit. Pancreatic (QUILT-88): Lymphopenia reversal prolonged OS in 3rd-6th line. NMIBC (QUILT-3.032): XX% CR rate DOR XX months"
X Link 2025-11-09T04:44Z 2780 followers, XXX engagements
"$IBRX @POTUS #ABOLISHTHEFDA A mother watches her 12-year-old waste away from glioblastoma while the FDA sits on paperwork. A father begs on his knees for Anktivathe drug already FDA-approved for bladder cancer already reversing lymphopenia and buying precious months in trialsyet the same agency says wait. Wait while the tumor grows. Wait while the child dies. This isnt caution. This is cruelty dressed up as regulation. Cancer doesnt file forms in triplicate. It kills. Every delayed approval every denied compassionate use every not enough data is another coffin. We are DONE watching our loved"
X Link 2025-11-25T14:14Z 2780 followers, 2976 engagements
"I understand that and share counts means nothing. $IBRX .98B Pharma companies with shares outstanding (Nov 2025) Pfizer (PFE) XXXX billion shares Novo Nordisk (NVO) XXXX billion shares AstraZeneca (AZN) XXXX billion shares Merck (MRK) XXXX billion shares Sanofi (SNY) XXXX billion shares Johnson & Johnson (JNJ) XXXX billion shares Bristol-Myers Squibb (BMY) XXXX billion shares GlaxoSmithKline (GSK) XXXX billion shares Novartis (NVS) XXXX billion shares AbbVie (ABBV) XXXX billion shares Chugai Pharmaceutical XXXX billion shares Gilead Sciences (GILD) XXXX billion shares"
X Link 2025-11-28T21:14Z 2779 followers, XXX engagements
"$IBRX There is a Strong Support for Dr. Patrick Soon-Shiongs FDA Meeting on Anktiva Dr. Patrick Soon-Shiong meting with the FDA today (Dec X 2025) to secure broader access to Anktiva for BCG-unresponsive papillary-only bladder cancer patients the group currently facing radical cystectomy (bladder removal) as their only remaining option. The evidence is now peer-reviewed and published in the Journal of Urology (Nov 2025 PMID 40956664): 36-month bladder preservation rate: XX% Disease-free survival: XX% Progression-free survival: XX% Only X% Grade X side effects zero Grade XX Median time to"
X Link 2025-12-03T16:38Z 2779 followers, 8358 engagements
"$IBRX ANKTIVA should be fast-tracked for two life-changing approvals and then yes move toward the boldest access possible: X. Papillary BCG-unresponsive NMIBC The 36-month data is published and undeniable: XX% bladder preservation XX% progression-free near-perfect safety. Thousands face cystectomy right now. Approve the label expansion immediately. X. Lymphopenia (low ALC) the silent killer hiding in plain sight on every CBC Low lymphocytes independently predict death across cancer chemo sepsis infection radiation and aging. Anktiva is the first and only therapy proven to reverse it by"
X Link 2025-12-04T15:08Z 2779 followers, 4663 engagements
"$IBRX: Oh look Andrew Caravello DCVaxdefender and the $NWBO clown Bag holders parade are back at it bravely declaring ANKTIVA is overhyped with no real-world impact and wont change outcomes. 😂 How adorable. Must be tough watching a real FDA-approved drug while clutching their 20-year-old PowerPoint slides. Reality check boys: XX% CR DoR stretching past XX months XX% of papillary patients still have their bladders Actual approval actual patients actual results Meanwhile DCVax-L is still doing the any day now dance outside the US. Keep coping kingsyour tears fuel the $IBRX rocket. 🚀🤡"
X Link 2025-12-05T05:25Z 2780 followers, 3718 engagements
"$IBRX with the new FDA policy updates cutting red tape IMO IF and when @ImmunityBio all ongoing trials get approved. huge potential and life changing opportunity ANKTIVA Peak U.S. Market Opportunities NMIBC (CIS + Papillary): $1.5B$2B Pancreatic (lymphopenia reversal): $1.2B$1.8B NSCLC (lymphopenia + checkpoint rescue): $2.5B$3.5B All Solid Tumors lymphopenia BioShield: $5B$7B Recurrent GBM: $2B$3B Long COVID immune restoration: $20B$100B (global XXX yr) Broad checkpoint combo upside: $20B$30B additive. We are looking at $60B-$130B+ market potential GLTL not an investment advice please do"
X Link 2025-12-05T17:05Z 2781 followers, 1385 engagements
"$IBRX BioShield for Lymphopenia my Bull Case w/ Projections FDA aggressively fast-tracking ANKTIVA as the first lymphocyte rescue agent (Neupogen for T/NK cells). Pure supportive-care label zero threat to chemo radiation or $MRKs Keytruda empire. Financial Projections (Analyst Consensus Dec 2025): 2025 Revenue: $100120M (up XXX% YoY on ANKTIVA bladder sales; YTD $43M thru Q2 +246% units) 2026 Revenue: $200500M base (lymphopenia launch Q1Q2 adds $150300M; peak potential $510B/yr in U.S. alone per market models capturing 5070% of metastatic patients) EPS: -$0.53 (2025) -$0.10 (2026);"
X Link 2025-12-07T04:43Z 2779 followers, 5135 engagements
"$IBRX ANKTIVA"
X Link 2025-12-07T12:23Z 2779 followers, 1342 engagements
"$IBRX ANKTIVA to the rescue"
X Link 2025-12-07T13:54Z 2780 followers, XXX engagements
"$IBRX Adam I know you are poking but @DrPatSoonShiong will never give you a time of the day. You know people can listen to what @ScottAdamsSays exact words and he never said ANKTIVA (Bioshield) not helping. You getting soft brother come on credibility is everything. STAT losing membership What is wrong brother Hope all is well"
X Link 2025-12-07T23:54Z 2779 followers, 1617 engagements
"$IBRX @DrPatSoonShiong on the world stage representing LA and USA proud of him ANKTIVA"
X Link 2025-12-08T00:17Z 2779 followers, 1933 engagements
"$IBRX ANKTIVA TO THE RESCUE@ScottAdamsSays"
X Link 2025-12-08T11:50Z 2778 followers, XXX engagements
"$IBRX ANKTIVA to the rescue @ScottAdamsSays"
X Link 2025-12-08T11:50Z 2778 followers, XXX engagements
"$IBRX an alarming situation"
X Link 2025-12-08T13:45Z 2780 followers, 1694 engagements
"$IBRX ANKTIVA to the recuse"
X Link 2025-12-08T13:41Z 2779 followers, 1123 engagements
"Open Letter to President Trump Mr. President You said God spared you for a reason. This is the reason. Right now ANKTIVA is quietly curing people doctors had already sentenced to death: XX% complete remission in the worst bladder cancer (most still cancer-free XX years later Stage-4 pancreatic patients alive XXX years after metastasis Kids with no options breathing again because their NK cells woke up and slaughtered the tumors One thousand Americans have already been saved. Ten thousand more are begging for access tonight. Theyre tagging you on X crying in waiting rooms holding up signs that"
X Link 2025-11-28T14:11Z 2779 followers, 47.3K engagements
"Here are my top SC biotech stocks $CADL $IBRX $IOVA these three among others may be a life changing opportunity $CAPR that was huge bank Not a financial advice please do your own DD"
X Link 2025-12-08T14:24Z 2779 followers, 1206 engagements